Immunomodulatory Effects of Pevonedistat, a NEDD8-Activating Enzyme (NAE) Inhibitor, in Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Best, Scott R. [1 ]
Kittai, Adam [2 ]
Rowland, Taylor [1 ]
Bruss, Nur [1 ]
Spurgeon, Stephen E. [2 ]
Berger, Allison [3 ]
Moran, Amy [1 ]
Danilov, Alexey V. [2 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[3] Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2946
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting Microenvironment-Mediated NFκb Activation With MLN4924, An Inhibitor Of The Nedd8-Activating Enzyme, In Chronic Lymphocytic Leukemia B Cells
    Godbersen, Claire
    Eastman, Alan
    Brown, Jennifer R.
    Danilov, Alexey V.
    BLOOD, 2013, 122 (21)
  • [32] Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
    Wang, Xiaofang
    Zhang, Wenjuan
    Yan, Zi
    Liang, Yupei
    Li, Lihui
    Yu, Xiaoli
    Feng, Yan
    Fu, Shen
    Zhang, Yanmei
    Zhao, Hu
    Yu, Jinha
    Jeong, Lak Shin
    Guo, Xiaomao
    Jia, Lijun
    ONCOTARGET, 2016, 7 (25) : 38380 - 38391
  • [33] Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVA51 oncolytic virotherapy
    Wong, Boaz
    Bergeron, Anabel
    Maznyi, Glib
    Ng, Kristy
    Jirovec, Anna
    Birdi, Harsimrat K.
    Serrano, Daniel
    Spinelli, Marcus
    Thomson, Max
    Taha, Zaid
    Alwithenani, Akram
    Chen, Andrew
    Lorimer, Ian
    Vanderhyden, Barbara
    Arulanandam, Rozanne
    Diallo, Jean -Simon
    MOLECULAR THERAPY, 2023, 31 (11) : 3176 - 3192
  • [34] The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia
    Leclerc, Gilles M.
    Zheng, Shuhua
    Leclerc, Guy J.
    DeSalvo, Joanna
    Swords, Ronan T.
    Barredo, Julio C.
    LEUKEMIA RESEARCH, 2016, 50 : 1 - 10
  • [35] Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma
    McMillin, Douglas W.
    Jacobs, Hannah M.
    Delmore, Jake E.
    Buon, Leutz
    Hunter, Zachary R.
    Monrose, Val
    Yu, Jie
    Smith, Peter G.
    Richardson, Paul G.
    Anderson, Kenneth C.
    Treon, Steven P.
    Kung, Andrew L.
    Mitsiades, Constantine S.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) : 942 - 951
  • [36] TRAF2 Regulates Hepatocellular Carcinogenesis Via Modulating the Activity of NEDD8-Activating Enzyme (NAE)
    Liang, Xue
    Yao, Jiping
    Zhao, Yongchao
    Zheng, Min
    HEPATOLOGY, 2018, 68 : 881A - 881A
  • [37] Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
    Y Ishikawa
    K Nakayama
    M Morimoto
    A Mizutani
    A Nakayama
    K Toyoshima
    A Hayashi
    S Takagi
    R Dairiki
    H Miyashita
    S Matsumoto
    K Gamo
    T Nomura
    K Nakamura
    Oncogenesis, 2017, 6 : e377 - e377
  • [38] Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
    Lockhart, A. Craig
    Bauer, Todd M.
    Aggarwal, Charu
    Lee, Carrie B.
    Harvey, R. Donald
    Cohen, Roger B.
    Sedarati, Farhad
    Nip, Tsz Keung
    Faessel, Helene
    Dash, Ajeeta B.
    Dezube, Bruce J.
    Faller, Douglas V.
    Dowlati, Afshin
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (01) : 87 - 97
  • [39] Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
    Torka, Pallawi
    Kambhampati, Swetha
    Chen, Lu
    Wang, Xiaoguang
    Chen, Canping
    Vuong, Dan
    Qin, Hanjun
    Muir, Alexandra
    Orand, Kirsten
    Borja, Ivana
    Lynne Smith, D.
    Herrera, Alex F.
    Spurgeon, Stephen E. F.
    Park, Byung
    Lewis, Lionel D.
    Hernandez-Ilizaliturri, Francisco
    Xia, Zheng
    Danilov, Alexey V.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [40] Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia
    Khalife, J.
    Radomska, H. S.
    Santhanam, R.
    Huang, X.
    Neviani, P.
    Saultz, J.
    Wang, H.
    Wu, Y-Z
    Alachkar, H.
    Anghelina, M.
    Dorrance, A.
    Curfman, J.
    Bloomfield, C. D.
    Medeiros, B. C.
    Perrotti, D.
    Lee, L. J.
    Lee, R. J.
    Caligiuri, M. A.
    Pichiorri, F.
    Croce, C. M.
    Garzon, R.
    Guzman, M. L.
    Mendler, J. H.
    Marcucci, G.
    LEUKEMIA, 2015, 29 (10) : 1981 - 1992
12345